TAK vs. MRK
Compare and contrast key facts about Takeda Pharmaceutical Company Limited (TAK) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TAK or MRK.
Correlation
The correlation between TAK and MRK is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TAK vs. MRK - Performance Comparison
Key characteristics
TAK:
0.61
MRK:
-1.41
TAK:
0.96
MRK:
-1.91
TAK:
1.12
MRK:
0.74
TAK:
0.25
MRK:
-0.89
TAK:
2.06
MRK:
-1.76
TAK:
5.48%
MRK:
20.40%
TAK:
18.59%
MRK:
25.36%
TAK:
-52.76%
MRK:
-68.62%
TAK:
-34.79%
MRK:
-39.66%
Fundamentals
TAK:
$45.76B
MRK:
$197.26B
TAK:
$0.45
MRK:
$6.74
TAK:
32.31
MRK:
11.63
TAK:
1.55
MRK:
0.72
TAK:
0.01
MRK:
3.07
TAK:
0.87
MRK:
4.26
TAK:
$3.53T
MRK:
$48.39B
TAK:
$2.02T
MRK:
$39.64B
TAK:
$764.83B
MRK:
$19.98B
Returns By Period
In the year-to-date period, TAK achieves a 9.82% return, which is significantly higher than MRK's -20.52% return. Over the past 10 years, TAK has underperformed MRK with an annualized return of -0.94%, while MRK has yielded a comparatively higher 6.98% annualized return.
TAK
9.82%
-3.13%
3.49%
12.90%
1.29%
-0.94%
MRK
-20.52%
-16.39%
-28.54%
-36.04%
2.91%
6.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TAK vs. MRK — Risk-Adjusted Performance Rank
TAK
MRK
TAK vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Takeda Pharmaceutical Company Limited (TAK) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TAK vs. MRK - Dividend Comparison
TAK's dividend yield for the trailing twelve months is around 2.29%, less than MRK's 4.03% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TAK Takeda Pharmaceutical Company Limited | 2.29% | 4.78% | 4.41% | 3.69% | 5.80% | 3.84% | 4.94% | 8.33% | 5.14% | 6.91% | 5.34% | 5.03% |
MRK Merck & Co., Inc. | 4.03% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
TAK vs. MRK - Drawdown Comparison
The maximum TAK drawdown since its inception was -52.76%, smaller than the maximum MRK drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for TAK and MRK. For additional features, visit the drawdowns tool.
Volatility
TAK vs. MRK - Volatility Comparison
The current volatility for Takeda Pharmaceutical Company Limited (TAK) is 7.43%, while Merck & Co., Inc. (MRK) has a volatility of 11.06%. This indicates that TAK experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TAK vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Takeda Pharmaceutical Company Limited and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities